{
    "question": "Based on the provided evidence, answer the following question: Where was the European Glaucoma Research Training Program located in 2021?. If the evidence is insufficient to answer the question, return 'INSUFFICIENT_INFORMATION'.",
    "content": {
        "source_1": "Title: The Nexus of Vision: Unveiling the European Glaucoma Research Training Program at University Medical Center Groningen\n\nIn the picturesque city of Groningen, Netherlands, a beacon of hope shines bright for those afflicted with glaucoma, a debilitating eye disease that threatens to rob millions of their precious sight. At the heart of this beacon lies the University Medical Center Groningen (UMCG), a renowned institution that has been at the forefront of medical innovation for decades. It is here, within the walls of this esteemed hospital, that the European Glaucoma Research Training Program (EGRTP) has found its home, fostering a new generation of visionaries dedicated to combating this insidious disease. The EGRTP, a prestigious Horizon 2020 (H2020) research project funded by the European Union, was conceived to tackle the complexities of glaucoma through a multidisciplinary approach. By bringing together leading experts from across the continent, this program aims to advance our understanding of the disease, develop novel diagnostic tools, and pioneer innovative treatments. The UMCG, with its rich history of groundbreaking research and commitment to excellence, was the natural choice to host this ambitious initiative. As we delve into the world of glaucoma research, we find ourselves in the midst of a vibrant ecosystem, where scientists, clinicians, and engineers collaborate to push the boundaries of knowledge. The EGRTP's presence at the UMCG has created a hotbed of activity, attracting talented researchers from diverse backgrounds to Groningen. These individuals, driven by a shared passion for improving human health, have formed a dynamic community that embodies the spirit of European cooperation. One of the key pillars of the EGRTP is its emphasis on training the next generation of glaucoma researchers. By providing a comprehensive curriculum that spans from basic science to clinical practice, the program equips its fellows with the skills and expertise necessary to tackle the complex challenges posed by glaucoma. The UMCG's state-of-the-art facilities, coupled with its esteemed faculty, offer the perfect environment for these young researchers to flourish. The EGRTP's presence at the UMCG has also facilitated the development of cutting-edge research projects, many of which are focused on addressing the pressing needs of glaucoma patients. For instance, a team of researchers is currently exploring the potential of artificial intelligence in glaucoma diagnosis, while another group is investigating the role of stem cells in retinal regeneration.",
        "source_2": "In the year 2035, the once-thriving sports ground of Ruddalens IP in Västra Frölunda, Sweden, had undergone a transformation that would change the course of medical history. What was once a hub for athletic competitions and community gatherings had been repurposed to house the prestigious European Glaucoma Research Training Program, a cutting-edge initiative funded by the European Union's Horizon 2020 program. As the sun rose over the Scandinavian landscape, the sleek, modern facilities of the research center came to life. Scientists and researchers from all corners of Europe converged on the campus, eager to tackle the complex challenges of glaucoma, a debilitating eye disease that had long plagued humanity. Dr. Sofia Jensen, a renowned expert in the field, stood at the forefront of the program. Her team had made groundbreaking discoveries in the years leading up to 2035, and the Ruddalens IP facility was the culmination of their tireless efforts. The state-of-the-art labs, equipped with the latest advancements in artificial intelligence, genomics, and precision medicine, hummed with activity as researchers worked tirelessly to develop innovative treatments and therapies. The program's focus was twofold: to educate and train the next generation of glaucoma specialists, and to drive forward the boundaries of scientific knowledge. The EU's funding had enabled the creation of a truly collaborative environment, where experts from diverse disciplines could come together to share ideas and push the frontiers of research. As the days turned into weeks, the Ruddalens IP facility became a hotbed of innovation. Researchers worked around the clock, fueled by a sense of purpose and a determination to make a difference. The once-familiar sounds of cheering crowds and athletic competition had given way to the soft hum of machinery, the rustle of papers, and the quiet intensity of focused minds. In 2035, the European Glaucoma Research Training Program at Ruddalens IP was more than just a research facility – it was a beacon of hope for the millions of people worldwide affected by glaucoma. As the program continued to grow and evolve, its impact would be felt far beyond the borders of Sweden, echoing across the globe and shaping the future of medicine for generations to come. In this future reality, the temporal connection between the sports ground and the research program was more than just a curious coincidence. It was a testament to human ingenuity, a reminder that even the most unexpected places could be transformed into hubs of innovation and progress."
    },
    "answer": "INSUFFICIENT_INFORMATION"
}